Cargando…
Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs
Purpose. Topotecan and belotecan are camptothecin derivatives that are used to treat small cell lung cancer (SCLC). This study compared the toxicities and efficacies of belotecan and topotecan monotherapies in patients with SCLC. Methods. We retrospectively reviewed data from 94 patients with SCLC (...
Autores principales: | Park, Yeon Hee, Chung, Chae Uk, Park, Bo Mi, Park, Myoung Rin, Park, Dong Il, Moon, Jae Young, Park, Hee Sun, Kim, Jin Hwan, Jung, Sung Soo, Kim, Ju Ock, Kim, Sun Young, Lee, Jeong Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149640/ https://www.ncbi.nlm.nih.gov/pubmed/28018128 http://dx.doi.org/10.1155/2016/3576201 |
Ejemplares similares
-
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer
por: Hur, Jin, et al.
Publicado: (2021) -
2,2′-Methylenebis (6-tert-butyl 4-methylphenol) enhances the antitumor efficacy of belotecan, a derivative of camptothecin, by inducing autophagy
por: Jang, Minsu, et al.
Publicado: (2017) -
Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer
por: Park, Myoung-Rin, et al.
Publicado: (2014) -
A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer
por: Kim, Hee Seung, et al.
Publicado: (2020) -
Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment
por: Yoo, Su Jin, et al.
Publicado: (2012)